← All themes Genomics & Gene Editing

Gene Therapy

Gene therapy delivers a working copy of a gene, or a correction to a faulty one, usually once and for life. Manufacturing the delivery vector is often harder than designing the therapy.

131 stocks

#	Name	Funds holding	Growth	Growth %	Fund value
101	KRBP 101 DELISTED Kiromic BioPharma, Inc. Common Stock KRBP	–	–	–	–
102	102 Kyverna Therapeutics KYTX $364M	–	–	–	–
103	103 Legend Biotech LEGN $3.84B	–	–	–	–
104	LGVN 104 Longeveron LGVN $4.56M	–	–	–	–
105	105 Lexeo Therapeutics LXEO $224M	–	–	–	–
106	106 Lyell Immunopharma LYEL $199M	–	–	–	–
107	107 Metagenomi Therapeutics MGX $31.9M	–	–	–	–
108	108 NewcelX Ltd NCEL $15.4M	–	–	–	–
109	109 DELISTED NKGen Biotech, Inc. Common Stock NKGN	–	–	–	–
110	110 Nkarta NKTX $138M	–	–	–	–
111	OBX 111 Obsidian Therapeutics OBX $758M	–	–	–	–
112	112 Passage Bio PASG $11.6M	–	–	–	–
113	113 PharmaCyte Biotech PMCB $3.85M	–	–	–	–
114	114 Prime Medicine PRME $628M	–	–	–	–
115	115 ProKidney PROK $305M	–	–	–	–
116	116 DELISTED Poseida Therapeutics, Inc. Common Stock PSTX	–	–	–	–
117	RCOR 117 DELISTED Renovacor, Inc. RCOR	–	–	–	–
118	118 Sana Biotechnology SANA $733M	–	–	–	–
119	SCPS 119 DELISTED Scopus BioPharma Inc. Common Stock SCPS	–	–	–	–
120	SCTX 120 Scribe Therapeutics Inc SCTX $392M	–	–	–	–
121	SGTX 121 DELISTED Sigilon Therapeutics, Inc. Common Stock SGTX	–	–	–	–
122	SLBT 122 SL Science Holding Ltd SLBT $948M	–	–	–	–
123	123 Senti Biosciences Holdings SNTI $7.66M	–	–	–	–
124	SQZ 124 DELISTED SQZ Biotechnologies Company SQZ	–	–	–	–
125	TCBP 125 DELISTED TC BioPharm (Holdings) plc American Depositary Shares TCBP	–	–	–	–